Renal oncocytoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(4 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Renal Oncocytoma}} | {{Renal Oncocytoma}} | ||
{{CMG}}{{AE}}{{Homa}} | |||
==Overview== | |||
There are no established measures for the [[secondary prevention]] of renal oncocytoma. | |||
==Secondary Prevention== | |||
There are no established measures for the [[secondary prevention]] of renal oncocytoma. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 01:42, 11 June 2019
Renal oncocytoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Renal oncocytoma secondary prevention On the Web |
American Roentgen Ray Society Images of Renal oncocytoma secondary prevention |
Risk calculators and risk factors for Renal oncocytoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There are no established measures for the secondary prevention of renal oncocytoma.
Secondary Prevention
There are no established measures for the secondary prevention of renal oncocytoma.